What type of study is this?

This is a Literature Review study.

September 10, 2025PharmaceuticsOpen Access

Advances in Gold Nanoparticles for the Diagnosis and Management of Alzheimer’s Disease

View Full Paper

Ask AI

Bookmark

Authors

BSBhagavathi Sundaram SivamaruthiChiang Mai University PKPeriyanaina KesikaChiang Mai University SNS. NatarajanSri Ramachandra Institute of Higher Education and Research

Discussion

Member takes

Implication

This review demonstrates advances in gold nanoparticles for Alzheimer's disease, suggesting innovative therapeutic strategies and highlighting challenges.

Key Points

Gold nanoparticles (AuNPs) show promise in improving diagnosis and therapeutic monitoring for Alzheimer's disease.
Recent advances include novel nanotherapeutic agents and strategies to enhance neuroprotective properties of AuNPs.
The review categorizes various AuNP types and discusses their link to the gut–brain axis, addressing blood-brain barrier challenges.
Future research should focus on optimizing AuNP properties and understanding Alzheimer's mechanisms for better treatment outcomes.

Cite This Study

Sivamaruthi et al. (2025) studied this question.

synapsesocial.com/papers/68c187209b7b07f3a061116b https://doi.org/10.3390/pharmaceutics17091158

View Full Paper

Ask AI

Bookmark

Implication

This review demonstrates advances in gold nanoparticles for Alzheimer's disease, suggesting innovative therapeutic strategies and highlighting challenges.

Advances in Gold Nanoparticles for the Diagnosis and Management of Alzheimer’s Disease

Discussion

Member takes

Implication

Key Points

Cite This Study

Advances in Gold Nanoparticles for the Diagnosis and Management of Alzheimer’s Disease

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider